The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
1α,25‐Dihydroxyvitamin D 3 modulates human adipocyte metabolism via nongenomic action
Abstract
We reported recently that suppression of the renal lα,25‐dihyroxyvitamin D 3 (lα,25‐(OH) 2 ‐D 3 ) production in aP2‐agouti transgenic mice by increasing dietary calcium decreases adipocyte intracellular Ca 2+ ([Ca 2+ ]i), stimulates lipolysis, inhibits lipogenesis, and reduces adiposity. However, it was not clear whether this modulation of adipocyte metabolism by dietary calcium is a direct effect of inhibition of lα,25‐(OH) 2 ‐D 3 ‐induced [Ca 2+ ]i. Accordingly, we have now evaluated the direct role of lα,25‐(OH) 2 ‐D 3 . Human adipocytes exhibited a lα,25‐(OH) 2 ‐D 3 dose‐responsive (1–50 nM) increase in [Ca 2+ ]i ( P < 0.01). This action was mimicked by lα,25‐dihyroxylumisterol 3 (lα,25‐(OH) 2 ‐lumisterol 3 ) ( P < 0.001), a specific agonist for a putative membrane vitamin D receptor (mVDR), and completely prevented by lβ,25‐dihydroxyvitamin D 3 (1β,25‐(OH )2 ‐D 3 ), a specific antagonist for the mVDR. Similarly, lα,25‐(OH )2 ‐D 3 (5 nM) caused 50%‐100% increases in adipocyte fatty acid synthase (FAS) expression and activity ( P < 0.02), a 61% increase in glycerol‐3‐phosphate dehydrogenase (GPDH) activity ( P < 0.01), and an 80% inhibition of isoproterenol‐stimulated lipolysis ( P < 0.001), whereas lβ,25‐(OH) 2 ‐D 3 completely blocked all these effects. Notably, lα,25‐(OH) 2 ‐lumisterol 3 exerted more potent effects in modulating adipocyte lipid metabolism, with 2.5‐ to 3.0‐fold increases in FAS expression and activity ( P < 0.001) and a threefold increase in GPDH activity ( P < 0.001). Also l α,25‐(OH)2‐lumisterol3 was approximately twice as potent in inhibiting basal lipolysis ( P < 0.025), whereas lβ,25‐(OH) 2 ‐D 3 completely blocked all these effects. These data suggest that l α,25‐(OH)2‐D3 modulates adipocyte Ca 2+ signaling and, consequently, exerts a coordinated control over lipogenesis and lipolysis. Thus, a direct inhibition of l α,25‐(OH) 2 ‐D 3 ‐induced [Ca 2+ ]i may contribute to an anti‐obesity effect of dietary calcium, and the mVDR may represent an important target for obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Structure-Function Relationships in the Vitamin D Endocrine System*
BOUILLON, R., OKAMURA, W. H., & NORMAN, A. W. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-200 · Cited by 1,235
Self-citationYoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-391 · Cited by 1,177
Regulation of adiposity by dietary calcium
Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., & Zemel, P. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1132 · Cited by 968
Self-citationLi, Y. C., Pirro, A. E., Amling, M., Delling, G., Baron, R., Bronson, R., & Demay, M. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9831 · Cited by 957
Evidence for alteration of the vitamin D-endocrine system in obese subjects.
Bell, N. H., Epstein, S., Greene, A., Shary, J., Oexmann, M. J., & Shaw, S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111971 · Cited by 685
Amling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J. M., Baron, R., & Demay, M. B. (1999) · Endocrinology · doi:10.1210/endo.140.11.7110 · Cited by 499
Calcium Intake and Body Weight1
Davies, K. M., Heaney, R. P., Recker, R. R., Lappe, J. M., Barger-Lux, M. J., Rafferty, K., & Hinders, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7063 · Cited by 402
Nemere, I., Dormanen, M. C., Hammond, M. W., Okamura, W. H., & Norman, A. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31579-x · Cited by 313
Self-citationShi, H., DiRienzo, D., & Zemel, M. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0584fje · Cited by 297
Self-citationDraznin, B., Sussman, K. E., Eckel, R. H., Kao, M., Yost, T., & Sherman, N. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113801 · Cited by 274
Caffrey, J. M., & Farach-Carson, M. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47057-9 · Cited by 243
Draznin, B., Sussman, K., Kao, M., Lewis, D., & Sherman, N. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47805-2 · Cited by 228
Nemere, I., Schwartz, Z., Pedrozo, H., Sylvia, V. L., Dean, D. D., & Boyan, B. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.9.1353 · Cited by 224
Mechanism of intracellular calcium ([Ca 2+ ] i ) inhibition of lipolysis in human adipocytes
Xue, B., Greenberg, A. G., Kraemer, F. B., & Zemel, M. B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0278fje · Cited by 218
Self-citationRole of intracellular calcium in human adipocyte differentiation
SHI, H., HALVORSEN, Y.-D., ELLIS, P. N., WILKISON, W. O., & ZEMEL, M. B. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.3.2.75 · Cited by 212
Self-citationMechanisms and Functions of Vitamin D
DeLuca, H. F., & Zierold, C. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01686.x · Cited by 187
Norman, A. W., Bouillon, R., Farach-Carson, M. C., Bishop, J. E., Zhou, L. X., Nemere, I., Zhao, J., Muralidharan, K. R., & Okamura, W. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80689-9 · Cited by 180
Self-citationCalcium Intake and Body Weight
Davies, K. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4635 · Cited by 179
The agouti gene product inhibits lipolysis in human adipocytes via a Ca 2+ ‐dependent mechanism
Xue, B., Moustaid‐Moussa, N., Wilkison, W. O., & Zemel, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1391 · Cited by 172
Self-citationJones, B. H., Kim, J. H., Zemel, M. B., Woychik, R. P., Michaud, E. J., Wilkison, W. O., & Moustaïd, N. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.1.e192 · Cited by 150
Self-citationAgouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice.
Zemel, M. B., Kim, J. H., Woychik, R. P., Michaud, E. J., Kadwell, S. H., Patel, I. R., & Wilkison, W. O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4733 · Cited by 141
Self-citationReceptors for 1α,25(OH)2D3: Past, Present, and Future
Norman, A. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.9.1360 · Cited by 123
Self-citationNorman, A. W., Okamura, W. H., Hammond, M. W., Bishop, J. E., Dormanen, M. C., Bouillon, R., BAELEN, H. V., Ridall, A. L., Daane, E., Khoury, R., et al. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.10.9993 · Cited by 123
Self-citationKajikawa, M., Ishida, H., Fujimoto, S., Mukai, E., Nishimura, M., Fujita, J., Tsuura, Y., Okamoto, Y., Norman, A. W., & Seino, Y. (1999) · Endocrinology · doi:10.1210/endo.140.10.7025 · Cited by 112
Self-citationA simple one-step enzymatic fluorometric method for the determination of glycerol in 20 μl of plasma
Boobis, L., & Maughan, R. J. (1983) · Clinica Chimica Acta · doi:10.1016/0009-8981(83)90245-0 · Cited by 102
The effects of calcium channel blockade on agouti ‐induced obesity
Kim, J. H., Mynatt, R. L., Moore, J. W., Woychik, R. P., Moustaid, N., & Zemel, M. B. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.14.9002558 · Cited by 94
Self-citationCytosolic Calcium and Insulin Resistance in Elderly Patients With Essential Hypertension
Byyny, R. L., Verde, M. L., Lloyd, S., Mitchell, W. D., & Draznin, B. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.7.459 · Cited by 94
Sánchez, M., de la Sierra, A., Coca, A., Poch, E., Giner, V., & Urbano-Márquez, A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.531 · Cited by 91
Annexin II is the membrane receptor that mediates the rapid actions of 1?,25-dihydroxyvitamin D3
Baran, D. T., Quail, J. M., Ray, R., Leszyk, J., & Honeyman, T. W. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000701)78:1<34::aid-jcb4>3.0.co;2-z · Cited by 88
The cellular ionic basis of hypertension and allied clinical conditions
Resnick, L. M. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70006-x · Cited by 72
Role of the sulfonylurea receptor in regulating human adipocyte metabolism
Shi, H., Moustaïd‐Moussa, N., Wilkison, W. O., & Zemel, M. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1833 · Cited by 69
Self-citationSecondary hyperparathyroidism of morbid obesity regresses during weight reduction
Andersen, T., McNair, P., Hyldstrup, L., Fogh‐Andersen, N., Nielsen, T. T., Astrup, A. V., & Transbøl, I. (1988) · Metabolism · doi:10.1016/0026-0495(88)90041-8 · Cited by 65
Baran, D. T., Sorensen, A. M., Shalhoub, V., Owen, T. A., Oberdorf, A. M., Stein, G. S., & Lian, J. B. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061202 · Cited by 64
Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism
Bell, N. H., Epstein, S., Shary, J., Greene, V. S., Oexmann, M. J., & Shaw, S. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030503 · Cited by 61
Shan, J. J., Resnick, L. M., Lewanczuk, R. Z., Karpinski, E., Li, B., & Pang, P. K. T. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.12.983 · Cited by 54
Norman, A. W., Nemere, I., Muralidharan, K. R., et al. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90237-f · Cited by 44
Self-citationEvidence that obesity does not influence the vitamin D-endocrine system in blacks
Epstein, S., Bell, N. H., Shary, J., Shaw, S., Greene, A. S., & Oexmann, M. J. (1986) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650010203 · Cited by 31
Vitamin D Receptors: Not Just in the Nucleus Anymore
Fleet, J. C. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1999.tb01779.x · Cited by 28
Cited by
Vitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement
Rosen, C. J., Adams, J. S., Bikle, D. D., Black, D. M., Demay, M. B., Manson, J. E., Murad, M. H., & Kovacs, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1000 · Cited by 765
The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults
Parikh, S. J., Edelman, M., Uwaifo, G. I., Freedman, R. J., Semega-Janneh, M., Reynolds, J., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031398 · Cited by 660
Calcium and Dairy Acceleration of Weight and Fat Loss during Energy Restriction in Obese Adults
Zemel, M. B., Thompson, W., Milstead, A., Morris, K., & Campbell, P. (2004) · Obesity Research · doi:10.1038/oby.2004.67 · Cited by 601
Self-citation
Metadata
- Authors
- Shi, H., Norman, A. W., Okamura, W. H., Sen, A., & Zemel, M. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 14
- Pages
- 1-15
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156807491
- Cited by
- 253
- References
- 39
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.